Pioglitazone Again Tied to Increased Risk for Bladder Cancer (FREE)

By Amy Orciari Herman Edited by Susan Sadoughi, MD The diabetes drug pioglitazone is associated with increased risk for bladder cancer, according to a large population-based study in The BMJ. Prior research has gone back and forth …
Source: Physician's First Watch current issue - Category: Primary Care Source Type: news